Pantoprazolo Zentiva Lab (Pantoprazole Sodium Sesquihydrate)

Pantoprazole Sodium Sesquihydrate, the active ingredient in Pantoprazolo Zentiva Lab, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat acid‑related disorders such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Pantoprazolo Zentiva Lab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazolo Zentiva Lab is a proton pump inhibitor that acts on the gastric acid secretion pathway. - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief of heartburn and promotes healing of erosive esophagitis. - Erosive esophagitis: accelerates mucosal healing and reduces recurrence. - Peptic ulcer disease: supports ulcer healing and helps prevent relapse. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the condition.

Pantoprazolo Zentiva Lab is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: increased intestinal gas. - Constipation: infrequent.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhoea. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Acute interstitial nephritis: kidney inflammation presenting with reduced urine output.

Before initiating therapy, consider patient‑specific factors and monitor for potential risks. - Renal impairment: dose adjustment may be required. - Hepatic impairment: use with caution in severe liver disease. - Elderly patients: monitor for electrolyte disturbances. - Concomitant use with drugs that increase gastric pH: assess need for dose timing. - Long‑term therapy: evaluate bone health and magnesium status. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Pantoprazole may affect the absorption or metabolism of several co‑administered medicines.

Major Interactions (Avoid): - Antifungal agents (ketoconazole, itraconazole): reduced absorption due to higher gastric pH. - HIV protease inhibitors (atazanavir, nelfinavir): decreased plasma concentrations. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of INR; monitor coagulation parameters. - Methotrexate: increased serum levels, especially at high doses. - Digoxin: possible increase in serum concentration; check levels periodically.